Siemens is reviewing Healthineers’ majority stake, CFO Handelsblatt told Reuters.

MUNICH (Reuters) – Siemens AG (OTC: ) is reviewing its major stake in medical technology subsidiary Siemens (ETR: ) Healthineers, the German technology group’s chief financial officer Ralf Thomas told the Handelblatt newspaper.

The partnership with the maker of MRI machines and laboratory systems is not enough to justify a capital commitment of 45 billion euros ($46.91 billion), Thomas told Handelblatt, citing how much Siemens’ 75% equity stake is worth.

“We are evaluating the economic opportunities for Siemens AG in the health care sector. Then we will take from this how much health professionals are a tool as an investment. Then we will draw conclusions from this,” he said and the results will be presented. At the end of 2025 on the Capital Markets Day.

Siemens AG In 2018, it spun off a subsidiary based in Erlangen, Germany and floated it on the stock exchange. Until now, Siemens has maintained a majority stake in Siemens Healthcare.

However, Thomas recently offered to sell about 5% to finance a takeover of US software company Altair.

Thomas said he remains committed to the rail segment, which investors have repeatedly asked him to test.

“The business is in good condition with us. I don’t see any desire to part with it at the moment,” he told Handelblatt.

($1 = 0.9592 EUR)